Key Highlights
- BioSkryb Genomics partners with the Human Cell Atlas (HCA) to advance single-cell technology research.
- HCA members gain access to BioSkryb’s multiomic tools, including ResolveDNA® and ResolveOME™ core kits.
- BioSkryb to participate in the HCA General Meeting in Milan, advancing collaboration.
Source: Business Wire
Notable Quotes
- “By partnering with the HCA, we can increase access to our powerful technology and develop new connections with other collaborating consortium members working toward major advances in the way diseases are diagnosed and treated.” — Suresh Pisharody, CEO at BioSkryb
- “We’re delighted that BioSkryb has recently joined HCA’s Commercial Discount Program to empower the science of HCA’s Collaborating members around the world.” — John Randell, Chief Alliance Officer at HCA
SoHC's Take
BioSkryb Genomics’ partnership with the Human Cell Atlas marks a significant advancement in the field of single-cell research. By integrating BioSkryb’s innovative technology into HCA’s global efforts, this collaboration is poised to accelerate the development of comprehensive human cell maps, fostering breakthroughs in precision medicine. With BioSkryb’s industry-leading PTA method, HCA collaborators will now have unparalleled access to detailed genomic insights, driving forward our understanding of complex diseases and enhancing research on a global scale.
